Ignite Creation Date:
2025-12-26 @ 11:10 AM
Ignite Modification Date:
2026-03-02 @ 4:57 PM
Study NCT ID:
NCT03518112
Status:
TERMINATED
Last Update Posted:
2022-11-04
First Post:
2018-04-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2017-0127
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |